Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma

Cancer Sci. 2009 Mar;100(3):520-8. doi: 10.1111/j.1349-7006.2008.01056.x. Epub 2008 Dec 11.

Abstract

We performed loss of heterozygosity (LOH) analysis on five chromosomal arms (1p, 3p, 9p, 10q, 17p) in hepatocellular carcinoma (HCC). Univariate analyses of 80 patients who underwent liver transplantation demonstrated significant correlations between cancer recurrence and the following variables: LOH on 3p26, LOH on 10q23, LOH on 17p13, tumor diameter > or = 5 cm, number of tumors > or = 4, histologic Grade 3, alpha-fetoprotein (AFP) > or = 400 ng/mL, American Joint Committee on Cancer (AJCC) pT classification, and portal invasion. Patients with LOH on 10q23 exhibited a significantly higher 3-year recurrence rate (38.9%vs 11.9%, P = 0.0009). Multivariate analysis identified LOH on 10q23, histologic Grade 3, tumor nodules > or = 4, and AFP > or = 400 ng/mL as the risk factors of advanced HCC recurrence. These results suggest that LOH on 10q23 is associated with metastatic recurrence of HCC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / pathology
  • Chromosomes, Human, Pair 10 / genetics*
  • Female
  • Humans
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / pathology
  • Loss of Heterozygosity*
  • Male
  • Microdissection
  • Middle Aged
  • Neoplasm Metastasis / genetics*
  • Polymerase Chain Reaction
  • Risk Factors